Brian Lestini
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 11
- Cancer Immunotherapy and Biomarkers 10
- CAR-T cell therapy research 4
- Colorectal Cancer Treatments and Studies 2
-
- Melanoma and MAPK Pathways 2
- Cell death mechanisms and regulation 2
- Co-authors
- Amit Roy (2 shared papers)Feng Yan (2 shared papers)Georgia Kollia (2 shared papers)Shruti Agrawal (2 shared papers)Roger Marchant (4 shared papers)Kandice Kottke‐Marchant (2 shared papers)Sharon M. Sagnella (2 shared papers)Gaurav Bajaj (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)ASAIO Journal (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Cancer Research (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesGermanySpain
In The Last Decade
Brian Lestini
20 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 86
- Oncology 566
- Cancer Research 156
- Immunology 194
- Pulmonary and Respiratory Medicine 219
- Pathology and Forensic Medicine 116
Countries citing papers authored by Brian Lestini
This map shows the geographic impact of Brian Lestini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Lestini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Lestini more than expected).
Fields of papers citing papers by Brian Lestini
This network shows the impact of papers produced by Brian Lestini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Lestini. The network helps show where Brian Lestini may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Lestini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 170 | |
| 2 | 2016 | 158 | |
| 3 | 2002 | 99 | |
| 4 | 2017 | 82 | |
| 5 | 2009 | 76 | |
| 6 | 2004 | 72 | |
| 7 | 2016 | 69 | |
| 8 | 2018 | 57 | |
| 9 | 2008 | 55 | |
| 10 | 2009 | 45 | |
| 11 | 2017 | 37 | |
| 12 | 2015 | 37 | |
| 13 | 2015 | 16 | |
| 14 | 2014 | 16 | |
| 15 | 1996 | 12 | |
| 16 | 1996 | 11 | |
| 17 | 2006 | 9 | |
| 18 | 2013 | 6 | |
| 19 | 2015 | 1 | |
| 20 | 2011 | 1 |
About Brian Lestini
Brian Lestini is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Pathology and Forensic Medicine, having authored 20 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Lung Cancer Treatments and Mutations (5 papers), CAR-T cell therapy research (4 papers), Immunotherapy and Immune Responses (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Melanoma and MAPK Pathways (2 papers), Cell Adhesion Molecules Research (2 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Oncology (566 citations), Cancer Research (156 citations), Immunology (194 citations), Pulmonary and Respiratory Medicine (219 citations) and Pathology and Forensic Medicine (116 citations). Brian Lestini has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Amit Roy, Feng Yan, Georgia Kollia, Shruti Agrawal, Roger Marchant, Kandice Kottke‐Marchant, Sharon M. Sagnella, Gaurav Bajaj, Bruce Pawel and Kelly C. Goldsmith. Their work appears in journals such as Journal of Clinical Oncology, ASAIO Journal, Journal for ImmunoTherapy of Cancer, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.